share_log

基石藥業-B:自願公告 - 基石藥業與三生製藥達成Nofazinlimab(抗PD-1單抗)在中國大陸地區的戰略合作及獨家許可協議

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES STRATEGIC PARTNERSHIP AND EXCLUSIVE LICENSING AGREEMENT WITH 3SBIO FOR NOFAZINLIMAB (ANTI-PD-1 ANTIBODY) IN MAINLAND CHINA

香港交易所 ·  Nov 1, 2023 06:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more